Compounds > zanamivir
Page last updated: 2024-08-24

zanamivir and Body Weight

zanamivir has been researched along with Body Weight in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abed, Y; Boivin, G; Pizzorno, A; Rhéaume, C1
Fukushi, M; Kubo, S; Kudo, K; Miyoshi-Akiyama, T; Yamamoto, K; Yamashita, M1
Crossman, L; Fenton, RJ; Gower, D; Morley, PJ; Owens, IJ; Parry, S; Wong, T1
Bush, K; Goloubeva, OG; Govorkova, EA; Leneva, IA; Webster, RG1

Other Studies

4 other study(ies) available for zanamivir and Body Weight

ArticleYear
Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Antiviral research, 2014, Volume: 105

    Topics: Animals; Antiviral Agents; Body Weight; Disease Models, Animal; Drug Therapy, Combination; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Lung; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oseltamivir; Survival Analysis; Treatment Outcome; Viral Load; Zanamivir

2014
Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Animals; Body Weight; Carbon Dioxide; Chemokines; Dogs; Drug Therapy, Combination; Female; Guanidines; Influenza A Virus, H1N1 Subtype; Lung; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Organ Size; Orthomyxoviridae Infections; Oxygen; Pressure; Pulmonary Surfactant-Associated Protein D; Pulmonary Surfactants; Pyrans; Sialic Acids; Survival Analysis; Viral Load; Zanamivir

2012
Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:11

    Topics: Administration, Intranasal; Animals; Antiviral Agents; Autoradiography; Body Weight; Female; Ferrets; Guanidines; Influenza A virus; Lung; Mice; Orthomyxoviridae Infections; Pyrans; Respiratory System; Sialic Acids; Zanamivir

1999
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10

    Topics: Acetamides; Acids, Carbocyclic; Animals; Antiviral Agents; Body Weight; Brain; Cyclopentanes; Disease Models, Animal; Dogs; Female; Guanidines; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H9N2 Subtype; Lung; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Pyrans; Sialic Acids; Treatment Outcome; Virus Replication; Zanamivir

2001